Heart Doc VIP with Dr. Joel Kahn

This week, Dr. Kahn brings back the topic of Mankai Duckweed, the smallest edible plant, which provides a complete protein profile, >200 polyphenols, B12, choline, folate, Omega-3s, and other nutrients. Mankai was previously available as a frozen cube but has returned to the market as a user-friendly powder. Mankai is available here: partners.eatmankai.com/AA-DRKAHN Other topics include a trial of ablation in atrial fibrillation, early cancer screening blood tests (Galleri), a new cholesterol medication, obicetrapib, soy intake and lower breast cancer risk, and the power of a calcium CT score of zero. Thanks to Xtend-Life and the discount code KAHN15 on xtendlife.com/products/xtend-quinol and all their other products.

In this episode, Dr. Kahn interviews Ben Tammetta, founder of H2Biohacker, about inhaled molecular hydrogen. They discuss the research behind it and its potential role in supporting health at the cellular level. Dr. Kahn has used molecular hydrogen daily for nearly a year and shares how he feels it has supported his health. Use discount code DrKahn200 at H2Biohacker, or visit this link.

This week, Dr. Kahn discusses a large study on the impact of whole-grain consumption on heart health. The review article also addresses the optimal number of daily servings for improving weight, blood pressure, blood sugar, and cholesterol. Dr. Kahn offers ideas for incorporating more whole grains into your daily diet. Other topics include movement span, medications that may lower dementia risk, hot liquids and cancer, weekend warrior activity, ProLon and heart function (www.prolonlife.com/drkahn), the role of CGMs, and, finally, a paper on cockroaches!  Please visit xtendlife.com for GG Pure and use discount code KAHN15.

This week, Dr. Kahn discusses two large new studies examining the role of routine coronary artery calcium CT scoring around age 61 and its impact on clinical outcomes. Dr. Kahn favors getting a first calcium CT score at age 45 or younger. One study found that potentially unnecessary statin use was three times higher when a calcium CT score was not available. Patients were also much more likely to follow their recommended treatment when calcium scoring results were available. The second study found that CT results led to a major change in therapy for one in five people. These are encouraging findings that further support the #TestNotGuess approach. Other topics include: Low cardiac risk at age 42 and long-term outcomes Working from home and prolonged sitting Piping-hot drinks and esophageal cancer Menopausal hormone therapy and heart risk The prevalence of omega-3 deficiency Ahiflower as an omega-3 supplement Blood pressure and dementia Gout and heart disease Thanks to Central Coast Live Foods. Use discount code DrKahn10 on Kraut Krackers and Trail Salad fermented crackers.

This week, Dr. Kahn discusses the widespread disappointment following Novartis' announcement that its 8,000-patient HORIZON trial of a lipoprotein(a)-lowering drug failed to meet its primary endpoint. The news came as a major surprise and disappointment to patients eagerly awaiting access to this medication. No additional details have been released, and there is not yet a published paper to review. Dr. Kahn discusses the possible reasons the trial failed and what he plans to do moving forward. Other topics include lifestyle factors associated with sudden cardiac arrest, mindfulness for elevated blood pressure, hormone therapy and the female brain during menopause, the risks of off-label testosterone therapy in men, GLP-1 medications and lifespan, Mounjaro and cardiovascular risk, TMAO and brain atrophy, statins and reduced dementia risk, and the connection between adverse pregnancy outcomes and future cardiovascular disease.  Dr. Kahn's new book, Don't Drop Dead, is available in print, audiobook, and Kindle formats on Amazon.  Finally, thanks to WellBean and its amazing bean bars. Use promo code DrKahn15 to save money on your order.